Schaftoside Inhibits NLRP3 Inflammasome Activation to Alleviate Atherosclerosis in Mice
Schaftoside reduces atherosclerosis by promoting NLRP3 protein degradation through a LAMP2A-dependent chaperone-mediated autophagy pathway in ApoE⁻/⁻ mice.
Schaftoside reduces atherosclerosis by promoting NLRP3 protein degradation through a LAMP2A-dependent chaperone-mediated autophagy pathway in ApoE⁻/⁻ mice.
A systematic review of 14 preclinical studies suggests the phyto-antioxidant rutin counteracts chemotherapy-induced heart toxicity by curbing oxidative stress, inflammation, ...
A review of preclinical research suggests that melatonin may mitigate toxicity from emerging environmental contaminants by modulating inflammatory, mitochondrial, and ...
A cross-sectional study of 144,887 participants reveals that both elevated TyG index and high MHR are independently and jointly associated ...
Researchers have isolated and characterized carbon dots from moxa smoke that demonstrate anti-inflammatory and anti-arthritic effects in experimental rheumatoid arthritis ...
A retrospective study of over 1,000 multiple sclerosis patients shows that while relapse rates and relapse-associated disability have declined over ...
A study using a scaffold-free organoid model has found that date seed oil partially attenuates mitochondrial and inflammatory dysfunction triggered ...
A study in mice reveals that myeloperoxidase deficiency paradoxically worsens tissue inflammation and oxidative stress in the liver and spleen ...
Genetic and pharmacological inhibition of Toll-like receptor 2 reduces age-associated immune cell infiltration and fibrotic remodeling in mouse pancreatic islets.
A narrative review synthesises clinical and experimental evidence on how gut microbiota dysbiosis links to insulin resistance and glucose dysfunction ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine